GSK raises profit outlook on strong vaccine, HIV drug sales
Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
As AI proliferates in pharma, regulators look to catch up in clinical trials
*please scroll down for all the latest news*
